About Us

Let Our Team Accelerate Your Research and Development

Our Team

Bing Jiang, Ph.D. | Founder & CEO

Connect on LinkedIn

Bing Jiang has spent 30 years, both academically and professionally, in the field of microbiology and biotechnology. With a PhD in pharmacology and biochemistry from Peking Union Medical College and a master’s degree in cell biology from Beijing Normal University, Jiang completed his postdoctoral training and contributed to the scientific research at UT Southwestern Medical Center. Before opening BioInnovatise in 2009, Jiang worked in biotechnology research organizations.

At BioInnovatise, Jiang oversees the laboratory production and company operation, and he consults researchers across the globe on their precision medicine research endeavors. He is an expert in many areas of microbiology, including molecular cloning, mutagenesis, recombinant proteins, stem cells, plasmid DNA production and purification, CRISPR / Cas9, and viral vector production.


Jiye Wang | Molecular Biology Production Associate 

Jiye Wang works with our molecular biology production team. With a master’s degree in biomedical engineering from Wuhan University and a bachelor’s degree in bioengineering from Huazhong Agricultural University, Wangs academic background lays a solid foundation for his work in molecular biology.

At BioInnovatise, Wang assists the production of our quick turnaround molecular biology productions, including lentivirus packaging, molecular cloning, mutagenesis, and high-volume plasmid DNA production.

Our Company and Laboratory

BioInnovatise is a growing, minority-owned biotechnology company that serves research and development laboratories in the I-270 Technology Corridor, BioCapital, and beyond. Our teams advise and produce custom projects that further the research of numerous startups, large pharmaceutical companies, academic labs, and government agencies, including the NIH and FDA.

We specialize in molecular biology products and services to advance research in the early discovery phases of cell and gene therapy, immunotherapy, precision medicine, regenerative medicine, stem cell research, and vaccine development.

Researchers rely on our commitment to high-quality production with minimal turnaround time. We look forward to supporting researchers in their pursuit of making new breakthroughs in their respective fields.